For: | Zhou B, Zhang SR, Chen G, Chen P. Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer. World J Gastroenterol 2023; 29(35): 5094-5103 [PMID: 37744290 DOI: 10.3748/wjg.v29.i35.5094] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i35/5094.htm |
Number | Citing Articles |
1 |
Yi Chen, Liu-Yan Li, Jian-Di Li, Rong-Quan He, Zhi-Guang Huang, Wan-Ying Huang, Jia-Yuan Luo, Yi-Wu Dang, Gang Chen, Dan-Ming Wei. Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405879
|
2 |
Shi-Qiong Zhou, Peng Wan, Sen Zhang, Yuan Ren, Hong-Tao Li, Qing-Hua Ke. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma. World Journal of Clinical Oncology 2024; 15(7): 859-866 doi: 10.5306/wjco.v15.i7.859
|